These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 20439528)

  • 21. Anti-RNA polymerase III antibodies in the diagnosis of scleroderma renal crisis in the absence of skin disease.
    Bhavsar SV; Carmona R
    J Clin Rheumatol; 2014 Oct; 20(7):379-82. PubMed ID: 25275766
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intriguing Relationships Between Cancer and Systemic Sclerosis: Role of the Immune System and Other Contributors.
    Maria ATJ; Partouche L; Goulabchand R; Rivière S; Rozier P; Bourgier C; Le Quellec A; Morel J; Noël D; Guilpain P
    Front Immunol; 2018; 9():3112. PubMed ID: 30687318
    [TBL] [Abstract][Full Text] [Related]  

  • 23. RNA polymerase III-positive systemic sclerosis in a patient with circumscribed morphea.
    Watson KD; Makol A
    Rheumatology (Oxford); 2017 Nov; 56(11):1856. PubMed ID: 29088451
    [No Abstract]   [Full Text] [Related]  

  • 24. Reply: To PMID 25512203.
    Hamaguchi Y; Kuwana M; Fujimoto M
    Arthritis Rheumatol; 2015 Sep; 67(9):2548. PubMed ID: 25988480
    [No Abstract]   [Full Text] [Related]  

  • 25. Malignancies in Patients with Anti-RNA Polymerase III Antibodies and Systemic Sclerosis: Analysis of the EULAR Scleroderma Trials and Research Cohort and Possible Recommendations for Screening.
    Lazzaroni MG; Cavazzana I; Colombo E; Dobrota R; Hernandez J; Hesselstrand R; Varju C; Nagy G; Smith V; Caramaschi P; Riccieri V; Hachulla E; Balbir-Gurman A; Chatelus E; Romanowska-Próchnicka K; Araújo AC; Distler O; Allanore Y; Airò P;
    J Rheumatol; 2017 May; 44(5):639-647. PubMed ID: 28089973
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Examination of autoantibody status and clinical features associated with cancer risk and cancer-associated scleroderma.
    Shah AA; Hummers LK; Casciola-Rosen L; Visvanathan K; Rosen A; Wigley FM
    Arthritis Rheumatol; 2015 Apr; 67(4):1053-61. PubMed ID: 25605296
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Scleroderma Renal Crisis: Risk Factors for an Increasingly Rare Organ Complication.
    Moinzadeh P; Kuhr K; Siegert E; Blank N; Sunderkoetter C; Henes J; Krusche M; Schmalzing M; Worm M; Schmeiser T; Günther C; Aberer E; Susok L; Riemekasten G; Kreuter A; Zeidler G; Juche A; Hadjiski D; Müller-Ladner U; Gaebelein-Wissing N; Distler JHW; Sárdy M; Krieg T; Hunzelmann N
    J Rheumatol; 2020 Feb; 47(2):241-248. PubMed ID: 30936287
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cardiopulmonary Disease Development in Anti-RNA Polymerase III-positive Systemic Sclerosis: Comparative Analyses from an Unselected, Prospective Patient Cohort.
    Hoffmann-Vold AM; Midtvedt Ø; Tennøe AH; Garen T; Lund MB; Aaløkken TM; Andreassen AK; Elhage F; Brunborg C; Taraldsrud E; Molberg Ø
    J Rheumatol; 2017 Apr; 44(4):459-465. PubMed ID: 28089974
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intrarenal arterial stiffness is increased in systemic sclerosis patients with anti-ribonucleic acid polymerase III antibodies.
    Rosato E; Navarini L; Gigante A; Cianci R; Margiotta D; Barbano B; Afeltra A
    Rheumatology (Oxford); 2017 Jun; 56(6):1039-1041. PubMed ID: 28340199
    [No Abstract]   [Full Text] [Related]  

  • 30. Paraneoplastic Systemic Sclerosis: Focus on Anti-RNA Polymerase III Antibodies.
    Heymann WR
    Skinmed; 2016; 14(1):39-40. PubMed ID: 27072728
    [No Abstract]   [Full Text] [Related]  

  • 31. Close temporal relationship between onset of cancer and scleroderma in patients with RNA polymerase I/III antibodies.
    Shah AA; Rosen A; Hummers L; Wigley F; Casciola-Rosen L
    Arthritis Rheum; 2010 Sep; 62(9):2787-95. PubMed ID: 20506513
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Demographic and clinical features of systemic sclerosis patients with anti-RNA polymerase III antibodies.
    Motegi S; Toki S; Yamada K; Uchiyama A; Ishikawa O
    J Dermatol; 2015 Feb; 42(2):189-92. PubMed ID: 25483258
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thrombotic microangiopathic nephropathy in scleroderma and lupus anticoagulant.
    Quereda C; Pascual J; Pardo A; Mampaso F; Gonzalo A; Ortuño J
    Nephron; 1991; 59(4):651-3. PubMed ID: 1766507
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical features of systemic sclerosis patients with anti-RNA polymerase III antibody in a single centre in Spain.
    Callejas-Moraga EL; Guillén-Del-Castillo A; Marín-Sánchez AM; Roca-Herrera M; Balada E; Tolosa-Vilella C; Fonollosa-Pla V; Simeón-Aznar CP
    Clin Exp Rheumatol; 2019; 37 Suppl 119(4):41-48. PubMed ID: 30767873
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interpretation of an Extended Autoantibody Profile in a Well-Characterized Australian Systemic Sclerosis (Scleroderma) Cohort Using Principal Components Analysis.
    Patterson KA; Roberts-Thomson PJ; Lester S; Tan JA; Hakendorf P; Rischmueller M; Zochling J; Sahhar J; Nash P; Roddy J; Hill C; Nikpour M; Stevens W; Proudman SM; Walker JG
    Arthritis Rheumatol; 2015 Dec; 67(12):3234-44. PubMed ID: 26246178
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of Anti-RNA Polymerase III Antibody-positive Systemic Sclerosis and Altered GPATCH2L and CTNND2 Expression in Scleroderma Renal Crisis.
    Stern EP; Guerra SG; Chinque H; Acquaah V; González-Serna D; Ponticos M; Martin J; Ong VH; Khan K; Nihtyanova SI; Harber M; Burns A; Mayes MD; Assassi S; Fonseca C; Denton CP
    J Rheumatol; 2020 Nov; 47(11):1668-1677. PubMed ID: 32173657
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Coexistence of mucosa-associated lymphoid tissue lymphoma and systemic sclerosis showing positive for anticentromere antibody and anti-RNA polymerase III antibody: A case report and published work review.
    Fukumoto T; Matsuoka H; Kitani M; Sugiyama M; Fukunaga A; Nishigori C
    J Dermatol; 2018 Dec; 45(12):e337-e339. PubMed ID: 29797523
    [No Abstract]   [Full Text] [Related]  

  • 38. Identification of autoantibodies to RNA polymerase II. Occurrence in systemic sclerosis and association with autoantibodies to RNA polymerases I and III.
    Hirakata M; Okano Y; Pati U; Suwa A; Medsger TA; Hardin JA; Craft J
    J Clin Invest; 1993 Jun; 91(6):2665-72. PubMed ID: 8390487
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of the autoimmune disease scleroderma with an immunologic response to cancer.
    Joseph CG; Darrah E; Shah AA; Skora AD; Casciola-Rosen LA; Wigley FM; Boin F; Fava A; Thoburn C; Kinde I; Jiao Y; Papadopoulos N; Kinzler KW; Vogelstein B; Rosen A
    Science; 2014 Jan; 343(6167):152-7. PubMed ID: 24310608
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nucleolar staining cannot be used as a screening test for the scleroderma marker anti-RNA polymerase I/III antibodies.
    Yamasaki Y; Honkanen-Scott M; Hernandez L; Ikeda K; Barker T; Bubb MR; Narain S; Richards HB; Chan EK; Reeves WH; Satoh M
    Arthritis Rheum; 2006 Sep; 54(9):3051-6. PubMed ID: 16948135
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.